Technical Program | AIChE

Technical Program

Technical Program for the 6th International Conference on CRISPR Technologies.

 

To View Abstract for CRISPR Conference please CLICK HERE  

...

Read more

Start Time End Time  
October 17, 2023 All Eastern Standard Time
    Day 1
8:00 AM 4:00 PM Registration
9:00 AM 9:10 AM Welcome Remarks by Chairs: Kristin Knouse, MIT, Andrew Anzalone, Prime Medicine, & Benjamin Kleinstiver, Harvard
9:10 AM 10:00 AM KEYNOTE: Base editing and prime editing: correcting mutations that cause genetic disease in cells, animals, and patients, David Liu, Broad Institute
10:00 AM 10:30 AM Morning Coffee Break Sponsored by Synthego
10:30 AM 12:25 PM CRISPR Biology, Tools, and Applications; Session Chairs: Jonathan Strecker & Andrew Anzalone
10:30 AM 10:55 AM Invited Speaker: CRISPR-like RNAs regulate expression of cas genes, Sergey Shmakov, NIH
10:55 AM 11:20 AM Invited Speaker: Uncovering the functional diversity of rare CRISPR-Cas systems with deep terascale clustering, Soumya Kannan, Broad Institute
11:20 AM 11:45 AM Invited Speaker: Precision genome editing with DNA-dependent DNA polymerases and exogenous DNA-containing templates, Erik Sontheimer, University of Massachusetts
11:45 AM 12:05 PM Selected Abstract: RNA-Guided Type V CRISPR Nucleases Are Small, Efficient Genome Editing Tools with Diverse Targeting Capabilities, Lisa M. Alexander, Metagenomi
12:05 PM 12:25 PM Selected Abstract: Dynamics and Mechanics of R-Loop Formation during DNA Interrogation By Cas12a from Different Species, Kevin Aris, Stanford University 
12:25 PM 1:25 PM Lunch 
1:25 PM 2:55 PM Epigenetic and RNA editing Session Chairs: Morgan Maeder & Kristin Knouse
1:25 PM 1:50 PM Invited Speaker: Unlocking OPERA Platform to Activate Transcription Factor, Venkat Krishnamurthy, Korro Bio
1:50 PM 2:15 PM Invited Speaker: Enhancing Genome and Transcriptome Engineering: New Approaches, New Challenges, Prashant Mali, UC San Diego
2:15 PM 2:35 PM Selected Abstract: Development of Cas12a for Multiplexed Genome-Scale Transcriptional Activation Yanjing Liu, The Broad Institute of MIT and Harvard
2:35 PM 2:55 PM Selected Abstract: Next-Generation Epigenome Editors As Tools for Basic Discovery and Therapeutic Intervention, Edwin Neumann, MIT, Whitehead Institute for Biomedical Research
2:55 PM 3:25 PM Afternoon Coffee Break 
3:25 PM 5:20 PM High-Throughput Functional Genomics Session Chairs: Kristin Knouse & Manda Arbab
3:25 PM 3:50 PM Invited Speaker: CRISPR-based decoding of disease-associated genomic variants, Richard Sherwood, Brigham and Women's Hospital
3:50 PM 4:15 PM Invited Speaker: Single-cell high-content screening via genomic perturbation profiling at scale, Paul Blainey, MIT and Broad Institute
4:15 PM 4:40 PM Invited Speaker: Karyocreate: A CRISPR-based technology to study chromosome-specific aneuploify by targeting human centromeres, Teresa Davoli, NYU
4:40 PM 5:00 PM Selected Abstract: Reprogramming Functional Transcription Factor Binding Sites in Regulatory DNA with Pooled Prime Editing, Michael Montgomery, Stanford University
5:00 PM 5:20 PM Selected Abstract: Mapping the Genetic Interaction Network of PARP Inhibitor Response, Jia Ling, Princeton University
5:20 PM 6:20 PM Poster Session 1 and Cocktail Reception Sponsored by Collaborative Center for X-linked Dystonia Parkinsonism
     
Start Time End Time  
October 18, 2023 All Eastern Standard Time
    Day 2
8:30 AM 4:00 PM Registration
9:00 AM 9:10 AM Welcome Remarks by Chair: Andrew Anzalone, Prime Medicine
9:10 AM 10:00 AM KEYNOTE: From reading the genome for risk to rewriting it for cardiovascular health, Sekar Kathiresan, Verve Therapeutics
10:00 AM 10:30 AM Morning Coffee Break
10:30 AM 12:25 PM Progress Towards The Clinic Session Chairs: Morgan Maeder & Manda Arbab
10:30 AM 10:55 AM Invited Speaker: Correcting Pathogenic Mutations via Prime Editing, Gerald Schwank, University of Zurich
10:55 AM 11:20 AM Invited Speaker: Base editing rescue of spinal muscular atrophy in cells and in mice, Mandana Arbab, Harvard Medical School
11:20 AM 11:45 AM Invited Speaker: Modularity of In Vivo CRISPR Therapies, Jonathan Phillips, Intellia Tx
11:45 AM 12:05 PM Selected Abstract: Gene Editing without Ex Vivo culture Evades Genotoxicity in Human Hematopoietic Stem Cells, Jing Zeng, Boston Children's Hospital
12:05 PM 12:25 PM Selected Abstract: Rapid, Definitive Treatment of Phenylketonuria in Variant-Humanized Mice with Corrective Editing, Dominique Brooks, University of Pennsylvania
12:25 PM 1:55 PM Lunch Workshop: Challenges for CNS Delivery Sponsored by Collaborative Center for X-linked Dystonia Parkinsonism; Session Chair: Mandana Arbab & Ben Kleinstiver
12:40 PM 12:55 PM Structure-activity relationships guided engineering of AAV capsids with optimized skeletal muscle, cardiac muscle, and CNS tropism, Charlie Albright, Affinia Therapeutics
12:55 PM 1:10 PM Invited Speaker: Targeted Gene Regulation in the CNS Using Engineered Zinc Finger Protein Transcription Factors, Andrew Young, Sangamo Therapeutics
1:10 PM 1:25 PM Invited Speaker: Teaching old AAVs new tricks: enhancing CNS gene delivery by engineering capsid-receptor interactions, Ben Deverman, Broad Institute of MIT